Cookson Peirce & Co’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-71,163	Closed	-$1.7M	–	204
2023 Q2	$1.7M	Buy	+71,163	New	+$1.7M	0.1%	82
2020 Q3	–	Sell	-14,997	Closed	-$727K	–	139
2020 Q2	$727K	Buy	14,997 +7,772	+108%	+$377K	0.07%	86
2020 Q1	$305K	Buy	+7,225	New	+$305K	0.04%	111